top of page
Protocol-Hub-logo

Dosage Protocol

Thymosin
Alpha 1

5mg

CATEGORY: Immunity/Anti-Inflammation

RECONSTITUTION PROTOCOL

  • Diluent Amount: 1mL Bacteriostatic Water

DOSAGE INSTRUCTIONS

  • Dosage Range: 1mg (20 units)

  • Dosage Frequency: Daily (before bed)

  • Route: Subcutaneous

  • Cycle Duration: 2 weeks 

  • Estimated Bottles Needed To Complete Cycle: 2 - 3 bottles

​

For research or educational purposes only. Suggested protocol only, consume at own risk. 

BPC-157

5mg

CATEGORY: Healing /Anti-Inflammatory

RECONSTITUTION PROTOCOL

  • Diluent Amount: 1mL Bacteriostatic Water

DOSAGE INSTRUCTIONS

  • Dosage Range: 0.5mg - 1.0mg (10 units-20units)

  • Dosage Frequency: 5 - 7 times per week

  • Route: Local IM or local subcutaneous or SubQ in Belly

  • Cycle Duration: 6 - 9 weeks or as needed

  • Estimated Bottles Needed To Complete Cycle: 4 - 8 bottles

​

For research or Educational purposes only. Suggested protocol only, consume at own risk. 

Notes & Precautions

  • Inject in fasted state, in AM

  • Individuals with autoimmune conditions should consult a qualified healthcare professional before using Thymosin Alpha-1 (TA1), as its effects on immune function could potentially influence or worsen certain autoimmune conditions.

Description

Thymosin Alpha-1 (Tα1) is an immunomodulatory peptide that supports several components of the immune system involved in recognizing and responding to infections. Rather than simply stimulating the immune system indiscriminately, it can help regulate and enhance immune responses involved in the body's defense against pathogens.

​

Thymosin Alpha-1 may support infection-related immune defenses by:

  • Enhancing T-cell activity and maturation, helping the immune system recognize and respond to infected cells.

  • Supporting natural killer (NK) cell function, which contributes to the destruction of virus-infected and other abnormal cells.

  • Promoting dendritic-cell function, improving the presentation of pathogen-related antigens and activation of adaptive immune responses.

  • Supporting innate and adaptive immunity, strengthening coordination between the body's immediate defenses and its more targeted immune response.

  • Modulating cytokine and inflammatory signaling, which may help produce a more appropriately regulated immune response during infection.

  • Supporting immune function in immunocompromised individuals, where normal immune responses to infection may be weakened.

​

Thymosin Alpha-1 has been investigated clinically for its potential to improve immune responses in several infectious diseases, particularly chronic viral infections. Its primary potential benefit is immune modulation—helping immune cells mount a more effective and appropriately regulated response to infection.

Go back
bottom of page